Cybin (CYBN.NE) has a PEG ratio of -3.18, below the Healthcare sector average of 0.46.
Get informed when a big investor buys or sells
+ Follow-3.18
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Cybin (CYBN.NE) currently reports a PEG ratio of -3.18. That is below the Healthcare sector average of 0.46. Use the charts on this page to explore Cybin's PEG ratio history and peer comparisons.
Cybin's PEG ratio of -3.18 is lower than the Healthcare sector average of 0.46. That is roughly 786.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Cybin's market price to a fundamental measure such as earnings, sales, or book value. At -3.18, CYBN.NE can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -3.18, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 0.46. From there, open related valuation or income-statement pages for Cybin, and consider following CYBN.NE for alerts when major investors trade the stock.
Cybin is classified in the Healthcare sector. On PEG ratio, it currently shows -3.18 versus a sector average near 0.46. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYBN.NE with unrelated industries.